Form 4: Aura Biosciences CEO Sells Shares to Cover Tax Obligations

Aura Biosciences CEO, Elisabet de los Pinos, sold 15,955 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Elisabet de los Pinos, CEO of Aura Biosciences, sold 15,955 shares of common stock on January 21, 2025.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $7.6704, with individual transactions ranging from $7.67 to $7.72.
• Following the transaction, Ms. de los Pinos directly owns 304,692 shares and indirectly owns 131,412 shares through the Elisabet de los Pinos Revocable Trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The price range of $7.67 to $7.72 is within the expected range for a stock sale of this type.
• The number of shares sold is relatively small compared to the total shares held by the CEO.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant.
• The transaction does not impact the company's operations or financial health.

Key Dates

Keywords

Aura Biosciences, Elisabet de los Pinos, stock sale, tax obligations, restricted stock units, insider trading, executive compensation